The cefoxitin disk test - what a clinical microbiologist needs to know

Clinical Microbiology Newsletter

Volumn 29, Issue 5, 2007, Pages 33-40

  Swenson, Jana M ^a   Skov, Robert ^b   Patel, Jean B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; OXACILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOMATION; CEFOXITIN DISK TEST; MICROBIOLOGY; PERFORMANCE; PREDICTION; QUALITY CONTROL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 33846921024     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2007.02.004     Document Type: Article

References (34)

1. NCCLS/CLSI. 2004. Performance standards for antimicrobial susceptibility testing; 14th informational supplement. NCCLS document M100-S14. NCCLS/CLSI, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th information supplement. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Niemeyer D.M., et al. Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus. J. Bacteriol. 178 (1996) 5464-5471
5. McKinney T.K., et al. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and β-lactamase regulators. J. Bacteriol. 183 (2001) 6862-6868
6. Felten A., et al. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-Screen latex agglutination test. J. Clin. Microbiol. 40 (2002) 2766-2771
7. Mougeot C., Guillaumat-Taillet J., and Libert J.M. Staphylococcus aureus: nouvelle detection de la resistance intrinseque par la methode de diffusion. Pathol. Biol. 49 (2001) 199-204
8. Swenson J.M., Tenover F.C., and the Cefoxitin Disk Study Group. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 43 (2005) 3818-3823
9. Swenson, J.M. et al. 2007. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn. Microbiol. Infect. Dis. In press.
10. Skov, R. et al. 2005. Evaluation of cefoxitin (FOX) 10 and 30 μg disks and Etest for prediction of methicillin resistance in S. aureus (MRSA), abstr. D-1733. In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
11. Hussain Z., et al. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J. Clin. Microbiol. 38 (2000) 752-754
12. Chambers H.F., Archer G., and Matsuhashi M. Low-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33 (2005) 424-428
13. Hirano L., and Bayer A.S. Beta-lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob. Agents Chemother. 35 (1987) 685-690
14. Thauvin-Eliopoulos E., et al. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by β-lactamase-hyperproducing Staphylococcus aureus. Antimicrob. Agents Chemother. 34 (1990) 728-732
15. Kline M.W., Mason Jr. E.O., and Kaplan S.L. Outcome of heteroresistant Staphylococcus aureus infections in children. J. Infect. Dis. 156 (1987) 205-208
16. Skov R.L., et al. Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods. J. Antimicrob. Chemother. 43 (1999) 467-475
17. Tonin E., and Tomasz A. β-Lactam-specific resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 30 (1986) 577-583
18. Swenson J.M., et al. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J. Clin. Microbiol. 39 (2001) 3785-3788
19. Salimnia, H., and W.J. Brown. 2005. Detection of oxacillin resistance in Staphylococcus aureus: comparison of Phoenix oxacillin and cefoxitin MICs, MicroScan oxacillin MIC, oxacillin and cefoxitin disk diffusion, and mecA gene detection, abstr. D-1731. In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
20. Engelhard, K. et al. 2005. The Vitek mecA prediction test for staphylococci, abstr. C-004. In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
21. Griffith, R. et al. 2005. mecA prediction test for staphylococci with the Vitek 2 system, abstr. C-006. In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
22. Sakoulas G., et al. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J. Clin. Microbiol. 39 (2001) 3946-3951
23. Spanu T., et al. Identification of methicillin-resistant isolates of Staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix system. Diagn. Microbiol. Infect. Dis. 48 (2004) 221-227
24. Yamazumi T., et al. Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J. Clin. Microbiol. 39 (2001) 3623-3626
25. Yamazumi T., et al. Comparison of the Vitek gram-positive susceptibility 106 card and the MRSA-Screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J. Clin. Microbiol. 39 (2006) 53-56
26. Gorwitz R.J., et al. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf
27. Corso A., et al. Improvement of a latex agglutination test for the evaluation of oxacillin resistance in coagulase-negative staphylococci. Diagn. Microbiol. Infect. Dis. 50 (2004) 223-225
28. Pape J., Wadlin J., and Nachamkin I. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J. Clin. Microbiol. 44 (2006) 2575-2576
29. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard -. 8th ed. (2006), Clinical and Laboratory Standards Institute, Wayne, PA CLSI document M2-A9.
30. Cauwelier B., et al. Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 389-392
31. Gueudet T., and Lemblé C. Comparison of five usual techniques for detection of methicillin-resistant Staphylococcus aureus. Pathol. Biol. 52 (2004) 617-621
32. Urbaskova P., et al. Detection of MRSA in a group of 752 strains of S. aureus using a cefoxitin disk. Epidemiol. Mikrobiol. Immunol. 53 (2004) 62-65
33. Pottumarthy S., Fritsche T.R., and Jones R.N. Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 51 (2005) 57-62
34. Montgomery, M., J. Bywater, and H. King. 2004. Accuracy of cefoxitin in detection of oxacillin resistance in staphylococci, abstr. D-64. In 44th Intersci. Conf. Antimicro. Agents Chemother. American Society for Microbiology, Washington, DC.